David Klonoff, M.D., F.A.C.P.

AIMBE College of Fellows Class of 2013
For leadership in developing and applying diabetes technology to monitor glucose, deliver insulin, manage glycemic data, and build closed-loop systems.

Redesigning diabetes technology to detect low blood sugar in older adults with diabetes and Alzheimer’s disease

Via Science Daily | December 6, 2022

Regenstrief Institute Research Scientist April Savoy, PhD, a human factors engineer and health services researcher, is developing and testing user-friendly health information tools and technology designed to enhance accessibility and value to older adults with both diabetes and Alzheimer’s disease, and their caregivers. Without numerous finger sticks, these tools and technology will be designed to provide patients, caregivers, and clinicians with glucose metrics needed to diagnose hypoglycemia and identify treatment options.

Older adults with Alzheimer’s and Type 1 or Type 2 diabetes have a high risk of low blood sugar, known as hypoglycemia, which is often undetected. Hypoglycemia can cause dizziness, confusion, mood changes, hospitalization, and even death. Diagnosis and treatment of hypoglycemia can prevent complications… Continue reading.